Venlo, the Netherlands, May 29, 2024 QIAGEN today announced the launch of its QIAseq Multimodal DNA/RNA Lib Kit. The new kit enables seamless preparation of DNA and RNA libraries for.
Fitch Ratings has affirmed Quest Diagnostics, Inc. s Long-Term Issuer Default Rating , senior unsecured revolving facility and senior unsecured notes at BBB .
The Rating Outlook remains.
What You Should Know: - Hartwig Medical Foundation, a provider in using comprehensive genetic profiling to improve cancer treatment, and Ultima Genomics, a developer of groundbreaking next-generation sequencing (NGS) technology, announce a groundbreaking collaboration. -
Fluent BioSciences, a cutting-edge life sciences company leading the charge in revolutionizing single-cell analysis through simple, cost-effective, and highly scalable single-cell RNA sequencing solutions is thrilled to announce the award of an NIH Small Business Innovation Research (SBIR) Phase II grant, funded by the National Institute of General Medical Sciences (NIGMS, 2 R44 GM137648).